Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

MedWellAI (MWAI) Net Cash Flow (2016 - 2025)

MedWellAI (MWAI) has disclosed Net Cash Flow for 11 consecutive years, with -$85718.0 as the latest value for Q4 2025.

  • On a quarterly basis, Net Cash Flow rose 83.36% to -$85718.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$97016.0, a 146.46% decrease, with the full-year FY2025 number at $343495.0, up 273.1% from a year prior.
  • Net Cash Flow was -$85718.0 for Q4 2025 at MedWellAI, up from -$178089.0 in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $2.0 million in Q2 2021 to a low of -$1.4 million in Q3 2021.
  • A 5-year average of $4309.6 and a median of -$67554.0 in 2022 define the central range for Net Cash Flow.
  • Peak YoY movement for Net Cash Flow: soared 2210.21% in 2021, then tumbled 1604.92% in 2024.
  • MedWellAI's Net Cash Flow stood at -$531609.0 in 2021, then skyrocketed by 89.81% to -$54197.0 in 2022, then soared by 44.24% to -$30220.0 in 2023, then crashed by 1604.92% to -$515226.0 in 2024, then skyrocketed by 83.36% to -$85718.0 in 2025.
  • Per Business Quant, the three most recent readings for MWAI's Net Cash Flow are -$85718.0 (Q4 2025), -$178089.0 (Q3 2025), and -$80911.0 (Q2 2025).